Ligand ID: YTZ Drugbank ID: DB06147(Sulfathiazole) Indication:Sulfathiazole is effective against a wide range of gram positive and gram negative pathogenic microorganisms. Although no longer used in humans, it is used in cattle. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.41A | 19.86 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.38A | 22.43 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.37A | 22.43 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.39A | 22.94 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU B 205CYH B 265PHE B 230GLN B 244 | 1.37A | 22.94 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU D 205CYH D 265PHE D 230GLN D 244 | 1.36A | 22.94 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU C 205CYH C 265PHE C 230GLN C 244 | 1.40A | 22.94 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.36A | 22.94 | None | ||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 11 | ASN B 141LEU B 114HIS D 146ALA B 126TRP B 133 | 1.39A | 21.4318.81 | None | ||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 727GLN A 468ASN A 705TYR A 732GLY A 44 | 1.71A | 12.1412.24 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 838CYH A 842PHE A 419TYR A 420 | 1.56A | 15.26 | None | ||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 9 | GLN A 224LEU A 89LEU A 90VAL A 231ALA A 195 | 1.70A | 13.80 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 245PHE A 287TRP A 290PRO A 243 | 1.79A | 15.26 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 316PHE A 287TRP A 290PRO A 243 | 1.42A | 15.26 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 240TRP A 290TYR A 238PRO A 243 | 1.64A | 15.26 | None | ||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.79A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.72A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6w01 | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 9 | GLN B 131LEU B 134ALA B 81VAL B 78ALA B 138 | 1.74A | 22.75 | None | ||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.68A | 21.25 | APR A 201 (-4.7A)NoneNoneNoneNone | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | SER A6964LEU A6857CYH A7007TRP A6987 | 1.76A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 8 | SER B4325CYH B4326PHE B4321PRO A6878 | 1.48A | NoneNoneNoneSAM A7104 (-3.9A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.37A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.69A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.70A | AMP A 201 ( 4.4A)NoneNoneNoneNone | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | SER A6964LEU A6857CYH A7007TRP A6987 | 1.77A | 18.82 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | SER D4325CYH D4326PHE D4321PRO C6878 | 1.44A | 17.69 | NoneNoneNoneSAM C7105 ( 3.9A) | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | SER B4325CYH B4326PHE B4321PRO A6878 | 1.45A | 17.69 | NoneNoneNoneSAM A7102 ( 3.8A) | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 185PHE A 216TYR A 233GLN A 221 | 1.78A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | LEU C 185PHE C 216TYR C 233GLN C 221 | 1.71A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 5 / 9 | GLN A 11LEU A -8LEU A 106ALA A 30VAL A 41 | 1.80A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.71A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6wen | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.65A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6wey | NSP3 (SARS-CoV-2) | 5 / 9 | LEU A 330LEU A 357ALA A 316VAL A 299ALA A 328 | 1.69A | None | |||
![]() | 3TYE_B_YTZB902_1 (DIHYDROPTEROATESYNTHASE) | 6wiq | NSP7 (SARS-CoV-2) | 3 / 3 | PHE A 49LYS A 2SER A 1 | 1.58A | 16.15 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 8 | SER B4325CYH B4326PHE B4321PRO A6878 | 1.47A | NoneNoneNoneSAH A7102 (-3.8A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 8 | SER D4325CYH D4326PHE D4321PRO C6878 | 1.46A | NoneNoneNoneSAH C7102 (-3.8A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | SER C6964LEU C6857CYH C7007TRP C6987 | 1.78A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | SER A6964LEU A6857CYH A7007TRP A6987 | 1.77A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | SER B4325CYH B4326PHE B4321PRO A6878 | 1.45A | NoneNoneNoneSFG A7103 ( 3.8A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | SER A6964LEU A6857CYH A7007TRP A6987 | 1.76A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | SER C6964LEU C6857CYH C7007TRP C6987 | 1.78A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | SER D4325CYH D4326PHE D4321PRO C6878 | 1.46A | NoneNoneNoneSFG C7103 ( 3.9A) | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 9 | GLN B 131LEU B 134ALA B 81VAL B 78ALA B 138 | 1.74A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.39A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU D 126LEU D 153ALA D 112VAL D 95ALA D 124 | 1.76A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.70A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.73A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | LEU C 126LEU C 153ALA C 112VAL C 95ALA C 124 | 1.75A | APR C 201 (-4.9A)NoneNoneNoneNone | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 8 | SER B4325CYH B4326PHE B4321PRO A6878 | 1.46A | NoneNoneNoneSAH A7101 (-3.9A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.47A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 8 | LEU A 185PHE A 216TYR A 233GLN A 221 | 1.77A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.36A | 22.94 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.44A | 19.51 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | SER E 371LEU E 368PHE E 342TRP E 436 | 1.63A | DMS E 901 ( 4.4A)NoneNoneDMS E 901 ( 3.9A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | SER A 371LEU A 368PHE A 342TRP A 436 | 1.65A | DMS A 901 ( 4.9A)NoneNoneDMS A 901 (-3.5A) | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | SER E 371LEU E 368PHE E 342TRP E 436 | 1.62A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.35A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | SER A 371LEU A 368PHE A 342TRP A 436 | 1.63A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | SER E 371LEU E 368PHE E 342TRP E 436 | 1.63A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.38A | None | |||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | LEU A 75GLN D 118ASN A 115ALA A 112GLY A 97 | 1.80A | 19.5521.36 | NoneEDO D 201 ( 4.4A)EDO D 201 (-3.4A)NoneEDO A 202 ( 4.9A) | ||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 126LEU C 153ALA C 112VAL C 95ALA C 124 | 1.68A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU E 126LEU E 153ALA E 112VAL E 95ALA E 124 | 1.66A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU D 126LEU D 153ALA D 112VAL D 95ALA D 124 | 1.69A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.69A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.68A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.70A | APR A 201 (-4.8A)NoneNoneNoneNone | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 126LEU C 153ALA C 112VAL C 95ALA C 124 | 1.69A | APR C 201 (-4.8A)NoneNoneNoneNone | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU E 126LEU E 153ALA E 112VAL E 95ALA E 124 | 1.69A | APR E 201 (-4.7A)NoneNoneNoneNone | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU D 126LEU D 153ALA D 112VAL D 95ALA D 124 | 1.73A | APR D 201 (-4.5A)NoneNoneNoneNone | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.70A | APR B 201 (-4.7A)NoneNoneNoneNone | |||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | LEU A 75GLN D 118ASN A 115ALA A 112GLY A 97 | 1.80A | 19.5521.36 | NoneEDO A 207 ( 4.7A)EDO A 207 (-3.9A)NoneNone | ||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU C 126LEU C 153ALA C 112VAL C 95ALA C 124 | 1.68A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU A 126LEU A 153ALA A 112VAL A 95ALA A 124 | 1.71A | None | |||
![]() | 5G44_A_YTZA1512_1 (NUCLEAR RECEPTORROR-GAMMA) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 9 | LEU B 126LEU B 153ALA B 112VAL B 95ALA B 124 | 1.72A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.40A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12NSP7 (SARS-CoV-2) | 4 / 8 | SER C 4CYH C 8PHE A 843TYR A 420 | 1.58A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 316PHE A 287TRP A 290PRO A 243 | 1.40A | None | |||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 727GLN A 468ASN A 705TYR A 732GLY A 44 | 1.64A | 12.1412.24 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 245PHE A 287TRP A 290PRO A 243 | 1.74A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 838CYH A 842PHE A 419TYR A 420 | 1.62A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | SER A 239PHE A 45TYR A 732PRO A 243 | 1.70A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 240TRP A 290TYR A 238PRO A 243 | 1.53A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | LEU A 205CYH A 265PHE A 230GLN A 244 | 1.37A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 240TRP A 290TYR A 238PRO A 243 | 1.58A | None | |||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 727GLN A 468ASN A 705TYR A 732GLY A 44 | 1.59A | 12.2812.02 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 245PHE A 287TRP A 290PRO A 243 | 1.78A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | SER A 236PHE A 45TYR A 728GLN A 468 | 1.30A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 4 / 8 | SER C 4CYH C 8PHE A 843TYR A 420 | 1.26A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 316PHE A 287TRP A 290PRO A 243 | 1.40A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 838CYH A 842PHE A 419TYR A 420 | 1.59A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 838CYH A 842PHE A 419TYR A 420 | 1.61A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 316PHE A 287TRP A 290PRO A 243 | 1.40A | None | |||
![]() | 5CP3_A_YTZA301_1 (LIGHT CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7HEAVY CHAIN OFANTIGEN-BINDINGFRAGMENT OFMONOCLONAL ANTIBODYOF 4C7) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | LEU A 727GLN A 468ASN A 705TYR A 732GLY A 44 | 1.64A | 12.2812.02 | None | ||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | SER A 236PHE A 45TYR A 728GLN A 468 | 1.30A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 240TRP A 290TYR A 238PRO A 243 | 1.57A | None | |||
![]() | 4J7U_D_YTZD802_1 (SEPIAPTERINREDUCTASE) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 4 / 8 | SER C 4CYH C 8PHE A 843TYR A 420 | 1.21A | None |